ExodusPoint Capital Management’s TFF Pharmaceuticals, Inc. Common Stock TFFP Stock Holding History

ExodusPoint Capital Management’s Portfolio TFFP Stock Details TFFP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-2,020	Closed	-$685K	–	2914
2021 Q1	$685K	Buy	2,020 +67	+3%	+$27.2K	0.01%	1145
2020 Q4	$699K	Buy	+1,953	New	+$752K	0.01%	1049

Other funds holding TFFP

DRW Securities Chicago, Illinois $7.21B AUM 20.54% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Gagnon Securities New York $433M AUM 29.08% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Carlson Capital Dallas, Texas $318M AUM 27.64% 1-Year Est. Return

GPCM

Granite Point Capital Management Boston, Massachusetts $4.9M AUM 38.41% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Gagnon Advisors New York $136M AUM 21.55% 1-Year Est. Return

ACA

Apis Capital Advisors New York $648M AUM 302.67% 1-Year Est. Return

ExodusPoint Capital Management's TFFP Position: Q2 2021 in Review

ExodusPoint Capital Management sold out of TFF Pharmaceuticals, Inc. Common Stock (TFFP) in Q2 2021, closing a stake of 2,020 shares — an estimated $685K sold.

ExodusPoint Capital Management first reported a position in TFFP in Q4 2020 and held it in 2 quarters. The position peaked at $699K in Q4 2020. 59 funds tracked by Wall St. Rank hold TFFP as of Q2 2021.

ExodusPoint Capital Management reported no remaining TFF Pharmaceuticals, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
ExodusPoint Capital Management sold 2,020 TFF Pharmaceuticals, Inc. Common Stock shares in Q2 2021, an estimated $685K.
ExodusPoint Capital Management first reported a position in TFF Pharmaceuticals, Inc. Common Stock in Q4 2020 and held it in 2 quarters.
ExodusPoint Capital Management's TFF Pharmaceuticals, Inc. Common Stock position peaked at $699K in Q4 2020.
59 funds tracked by Wall St. Rank held TFF Pharmaceuticals, Inc. Common Stock as of Q2 2021.

Based on ExodusPoint Capital Management's 13F filing for Q2 2021, filed 16 Aug 2021.